NL-OMON34068已完成不适用
Study of the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple oral dosing in healthy subjects including brain Serotonin Transporter (SERT) occupancy by Positron Emission Tomography (PET). - MAD/PET study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Eli Lilly
- 入组人数
- 51
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male or female (post-menopausal or surgically sterile), age between18 and 65 years, BMI between 19 and 32.5 kg/m2, non-smoker or light to moderate smoker, at screening state of healthy must satisfy the entry requirements.;Addition Part B:
- •Non-exposure to any radiation for diagnostic reasons during work or during participation in a medical trial in the past year, non claustrophobic.
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 60 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters (for men)/1.0 liters (for women) of blood in the 10 months prior the start of this study.
研究者
相似试验
已完成
不适用
Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance after Multiple Oral Dosing of LY2623091 in Healthy VolunteersKidney failure10038430chronic kidney diseaseNL-OMON36630Eli Lilly32
进行中（未招募）
1 期
Safety, tolerability, and pharmacokinetics study of turoctocog alfa pegol injected under the skin in patients with haemophilia AEUCTR2016-002396-99-FRovo Nordisk A/S36
进行中（未招募）
1 期
Safety, tolerability, and pharmacokinetics study of turoctocog alfa pegol injected under the skin in patients with haemophilia AHaemophilia AMedDRA version: 19.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2016-002396-99-DEovo Nordisk A/S48
进行中（未招募）
1 期
Safety, tolerability, and pharmacokinetics study of turoctocog alfa pegol injected under the skin in patients with haemophilia AEUCTR2016-002396-99-BGovo Nordisk A/S36
进行中（未招募）
1 期
Safety, tolerability, and pharmacokinetics study of turoctocog alfa pegol injected under the skin in patients with haemophilia AEUCTR2016-002396-99-GBovo Nordisk A/S36